DFWIX
Price
$19.27
Change
-$0.14 (-0.72%)
Updated
Jun 3 closing price
Net Assets
5.61B
VFWPX
Price
$176.01
Change
-$1.41 (-0.79%)
Updated
Jun 3 closing price
Net Assets
90.68B
Interact to see
Advertisement

DFWIX vs VFWPX

Header iconDFWIX vs VFWPX Comparison
Open Charts DFWIX vs VFWPXBanner chart's image
DFWIX vs VFWPX Comparison Chart in %
View a ticker or compare two or three
VS
DFWIX vs. VFWPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFWIX is a Buy and VFWPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFWPX has more cash in the bank: 90.7B vs. DFWIX (5.61B). DFWIX pays higher dividends than VFWPX: DFWIX (2.81) vs VFWPX (2.62). DFWIX was incepted earlier than VFWPX: DFWIX (13 years) vs VFWPX (15 years). DFWIX (0.30) is less costly to investors than VFWPX (0.03). DFWIX is a more actively managed with annual turnover of: 8.00 vs. VFWPX (6.00). DFWIX has a lower initial minimum investment than VFWPX: DFWIX (0) vs VFWPX (100000000). DFWIX annual gain was more profitable for investors over the last year : 34.25 vs. VFWPX (30.83). DFWIX return over 5 years is better than : 54.27 vs. VFWPX (35.99).
DFWIXVFWPXDFWIX / VFWPX
Total Expense Ratio0.300.031,000%
Annual Report Gross Expense Ratio0.300.031,000%
Fund Existence13 years15 years-
Gain YTD15.42715.68598%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B90.7B6%
Annual Yield % from dividends2.812.62107%
Returns for 1 year34.2530.83111%
Returns for 3 years75.1161.34122%
Returns for 5 years54.2735.99151%
Returns for 10 years141.51107.69131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPSM1.560.15
+10.64%
Epsium Enterprise Limited
REGN618.9516.03
+2.66%
Regeneron Pharmaceuticals
IEP7.46-0.07
-0.93%
Icahn Enterprises LP
IKT1.68-0.02
-1.18%
Inhibikase Therapeutics
SMPL11.42-0.39
-3.30%
Simply Good Foods Company (The)